eliquis apixaban logo eliquis apixaban logo eliquis apixaban logo

This information is intended for healthcare professionals based in the UK.

If you are not a healthcare professional in the UK, please click here.

For Prescribing and Adverse Event reporting information, click here.

desk-img mob-img
Home / HCP / Resources / Risk Minimisation Materials

Risk minimisation materials

The ELIQUIS® (apixaban) Prescriber Guide and Patient Alert Card are risk minimisation materials developed for all indications, aimed at increasing awareness about the potential risk of bleeding during treatment with apixaban and providing guidance on how to manage that risk.

More information on each of these documents can be found
at www.medicines.org.uk/emc/product/2878/rmms (5 mg)

or www.medicines.org.uk/emc/product/4756/rmms (2.5 mg).
Diagnosemethoden

Full prescribing information is in the ELIQUIS SmPC

VIEW SmPC

Download guides designed for your patients

GO TO PATIENT
MATERIALS
ELIQUIS (apixaban) SmPC

Please click here to access the ELIQUIS SmPC.

ELIQUIS (apixaban) Patient Information Leaflet

Please click here to access the ELIQUIS Patient Information Leaflet.

You may contact our EU Data Protection Officer at EUDPO@BMS.com to exercise any data privacy rights that you may have, as well as to raise any concerns or questions in relation to the handling of your personal data by Bristol-Myers Squibb Company.

bristol myers squibb pfizer logo

© 2018 Bristol-Myers Squibb Pharmaceuticals Limited

All corporate names and logos of BMS and/or of its products are trademarks of Bristol-Myers Squibb Company and are protected by national and international intellectual and industrial property laws. All rights reserved over the content of this website.

Your use of this website is subject to the Legal Notice, the Privacy and Cookie Policy, the Pharmacovigilance Notice and the applicable laws and regulations.

432UK1700313-01
Date of preparation: March 2017